Literature DB >> 31239953

Opioid Toxicity.

David Dolinak1.   

Abstract

In recent years, there has been a substantial increase in opioid use and abuse, and in opioid-related fatal overdoses. The increase in opioid use has resulted at least in part from individuals transitioning from prescribed opioids to heroin and fentanyl, which can cause significant respiratory depression that can progress to apnea and death. Heroin and fentanyl may be used individually, together, or in combination with other substances such as ethanol, benzodiazepines, or other drugs that can have additional deleterious effects on respiration. Suspicion that a death is drug-related begins with the decedent's medical and social history, and scene investigation, where drugs and drug paraphernalia may be encountered, and examination of the decedent, which may reveal needle punctures and needle track marks. At autopsy, the most significant internal finding that is reflective of opioid toxicity is pulmonary edema and congestion, and frothy watery fluid is often present in the airways. Various medical ailments such as heart and lung disease and obesity may limit an individual's physiologic reserve, rendering them more susceptible to the toxic effects of opioids and other drugs. Although many opioids will be detected on routine toxicology testing, more specialized testing may be warranted for opioid analogs, or other uncommon, synthetic, or semisynthetic drugs.

Entities:  

Keywords:  Fentanyl; Forensic pathology; Heroin; Opiate; Opioid; Respiratory depression

Year:  2017        PMID: 31239953      PMCID: PMC6474471          DOI: 10.23907/2017.003

Source DB:  PubMed          Journal:  Acad Forensic Pathol        ISSN: 1925-3621


  7 in total

1.  Quantifying enhanced risk from alcohol and other factors in polysubstance-related deaths.

Authors:  Zheng Dai; Marie A Abate; D Leann Long; Gordon S Smith; Theresa M Halki; James C Kraner; Allen R Mock
Journal:  Forensic Sci Int       Date:  2020-05-31       Impact factor: 2.395

2.  Prevalence of Respiratory Disorders during Sleep among Subjects of Methadone Maintenance Therapy Program.

Authors:  Ali Talaei; Fahimeh Afzaljavan; Shabnam Niroumand; Raheleh Nejati
Journal:  Addict Health       Date:  2021-07

3.  Pharmacokinetics of Buprenorphine Buccal Film and Orally-administered Oxycodone in a Respiratory Study: An Analysis of Secondary Outcomes from a Randomized Controlled Trial.

Authors:  Lynn R Webster; Jacqueline Cater; Thomas Smith
Journal:  Pain Ther       Date:  2022-05-07

4.  Combined effects of quetiapine and opioids: A study of autopsy cases, drug users and sedation in rats.

Authors:  Freja Drost Andersen; Sâmia Joca; Victor Hvingelby; Shokouh Arjmand; Estefano Pinilla; Simon Comerma Steffensen; Ulf Simonsen; Charlotte Uggerhøj Andersen
Journal:  Addict Biol       Date:  2022-09       Impact factor: 4.093

5.  Genetic variation regulates opioid-induced respiratory depression in mice.

Authors:  Jason A Bubier; Hao He; Vivek M Philip; Tyler Roy; Christian Monroy Hernandez; Rebecca Bernat; Kevin D Donohue; Bruce F O'Hara; Elissa J Chesler
Journal:  Sci Rep       Date:  2020-09-11       Impact factor: 4.379

Review 6.  The Physiology and Maintenance of Respiration: A Narrative Review.

Authors:  Lynn R Webster; Suzanne Karan
Journal:  Pain Ther       Date:  2020-10-06

7.  A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration on Respiratory Drive.

Authors:  Lynn R Webster; Erik Hansen; Jacqueline Cater; Thomas Smith
Journal:  Adv Ther       Date:  2020-09-25       Impact factor: 3.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.